tallózása szerző szerint "Jakucs, J"

1-2 / 2

Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study).

Schneider, Tamás; Rosta, András; Losonczy, Hajnalka; Radvanyi, G; Ujj, G; Egyed, Miklós; Illés, Árpád; Jakucs, J; Szerafin, László; Gasztonyi, Z; Masszi, Tamás; Ivanyi, J; Demeter, Judit; Dombi, János Péter; Toth, A; Borbényi, Zita (2018)

Follicular lymphoma is a lymphoid malignancy commonly showing slow progression which makes the treatment of the disease challenging. Rituximab monotherapy and rituximab added to standard chemotherapy has been proven to ...
Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

Mesa, RA; Vannucchi, AM; Mead, A; Egyed, Miklós; Szoke, A; Suvorov, A; Jakucs, J; Perkins, A; Prasad, R; Mayer, J; Demeter, Judit; Ganly, P; Singer, JW; Zhou, H; Dean, JP; te, Boekhorst PA; Nangalia, J; Kiladjian, J-J; Harrison, CN (2017)

1-2 / 2

Keresés